VAPT Testing Requirements for US Healthcare Technology Providers

A healthcare technology provider can pass a compliance review and still have a vulnerability waiting to be exploited. That is the uncomfortable gap between being compliant on paper and knowing what an attacker could actually reach. A forgotten API endpoint, an exposed cloud service, an outdated software component, or a weakness in an application handling electronic protected health information (ePHI) may not appear in a policy document but it can become the starting point for a serious security incident. For healthcare technology providers in the USA, this distinction matters more as organizations connect EHRs, patient portals, APIs, cloud platforms, medical devices, third-party applications, and remote services. Every connection expands the environment that needs to be understood and tested.

This is where Vulnerability Assessment and Penetration Testing (VAPT) becomes valuable. Rather than treating security as a checklist, VAPT puts systems under scrutiny to identify vulnerabilities and determine how those weaknesses could potentially be exploited. But what exactly are the VAPT Requirements for Healthcare Technology Providers in USA? Does HIPAA require penetration testing? How often should vulnerability assessments be performed? And where do HIPAA, NIST, FDA cybersecurity expectations, and emerging regulatory requirements fit into the picture?

The answers are more nuanced than simply “run a penetration test once a year.” For healthcare technology companies, the real question is whether their security testing reflects the systems, data, technologies, and risks they actually operate today.

What Is VAPT in Healthcare?

In healthcare technology, finding a vulnerability is only part of the story. The bigger question is what that vulnerability could expose if someone actually tried to exploit it.

Vulnerability Assessment and Penetration Testing (VAPT) brings together two complementary approaches to answer both questions. A vulnerability assessment systematically identifies weaknesses across an environment, such as outdated software, missing patches, insecure configurations, exposed services, and known vulnerabilities. It gives organizations visibility into where security weaknesses exist.

Penetration testing takes the analysis further by simulating attempts to exploit those weaknesses within an agreed scope. It can reveal whether a vulnerability could provide unauthorized access, allow movement between systems, or expose sensitive information. In other words, vulnerability assessment identifies potential weaknesses, while penetration testing examines what those weaknesses could mean in practice.

NIST SP 800-115, Technical Guide to Information Security Testing and Assessment, includes vulnerability scanning and penetration testing among the techniques organizations can use to evaluate their security. It also emphasizes that no single testing technique provides a complete view of an organization's security posture.

For a healthcare technology provider, that broader view is important because the attack surface rarely ends at the organization's primary network. Depending on the technology and services involved, a VAPT assessment may examine:

• Web applications and patient portals
• APIs and healthcare integrations
• Cloud infrastructure and externally exposed services
• Internal and external networks
• Mobile healthcare applications
• Authentication and access controls
• Connected medical devices and supporting systems
• Systems that create, receive, maintain, or transmit ePHI

The exact scope should reflect the organization's technology environment and risk profile rather than follow a one-size-fits-all checklist. This makes VAPT relevant across SaaS vendors, digital health companies, healthcare software providers, medical technology organizations, and business associates operating in the USA.

Identify Vulnerabilities Before They Become Security Incidents. Explore INTERCERT’s VAPT Services for applications, APIs, networks, cloud, and healthcare technology.

Does HIPAA Require VAPT?

One of the most important questions around VAPT requirements for healthcare companies in the USA is whether HIPAA explicitly requires vulnerability assessments or penetration testing. The current HIPAA Security Rule requires covered entities and business associates to conduct an accurate and thorough assessment of risks and vulnerabilities affecting the confidentiality, integrity, and availability of ePHI. It also requires organizations to periodically evaluate the effectiveness of their security measures and make changes when necessary. HHS considers risk analysis a foundational requirement of the Security Rule.

However, HIPAA does not currently prescribe a universal VAPT schedule, such as requiring every healthcare organization to conduct a penetration test annually. Instead, its requirements are risk-based, meaning the security measures an organization adopts should reflect the risks associated with its environment, systems, and ePHI. VAPT can be an important technical component of that risk management process: vulnerability assessments can identify weaknesses such as missing patches, outdated software, and exposed services, while penetration testing can determine whether selected weaknesses can actually be exploited. HHS's January 2026 cybersecurity guidance specifically identifies vulnerability scanning as a method for detecting vulnerabilities, missing patches, and obsolete software.

For healthcare technology providers in USA, the practical question therefore goes beyond whether HIPAA uses the term “VAPT.” Organizations should consider whether their risk profile warrants technical testing across applications, APIs, cloud environments, networks, and systems that handle ePHI. A well-scoped VAPT can provide evidence of how vulnerabilities are identified and evaluated, while also revealing weaknesses that may not be apparent through policies or documentation alone. The objective is not simply to perform a test to satisfy a checklist, but to ensure that security risks affecting critical healthcare technology are being identified, understood, and addressed.

What Could Change Under the Proposed HIPAA Security Rule?

Healthcare organizations in the USA should also pay attention to the 2024 HIPAA Security Rule Notice of Proposed Rulemaking. HHS proposed more specific cybersecurity requirements, including vulnerability scanning at least every six months and penetration testing at least once every 12 months. The proposal also includes requirements relating to technology asset inventories, network maps, risk analysis, network segmentation, multifactor authentication, and testing the effectiveness of certain security measures.

Importantly, these are proposed requirements. HHS states that the current Security Rule remains in effect while the rulemaking process continues. This should remain clear when discussing VAPT compliance requirements for healthcare companies. Organizations should not treat the proposed testing frequencies as current HIPAA mandates. However, the proposal provides a useful indication of the direction of healthcare cybersecurity expectations in the USA. It also gives healthcare technology providers a reason to examine whether their current testing program would be able to meet more prescriptive requirements if they become applicable.

Who Should Consider VAPT?

The VAPT requirements for healthcare technology companies vary based on the systems they operate, the information they handle, and their role within the healthcare ecosystem. While VAPT can be relevant to many organizations, certain healthcare technology environments have a particularly broad or sensitive attack surface.

Healthcare SaaS and Software Companies

Healthcare software can connect patients, providers, EHRs, third-party applications, and cloud services, creating multiple points where vulnerabilities may affect sensitive information or connected systems. For these organizations, VAPT requirements for healthcare software companies may include:

• Web applications and patient portals: Identify weaknesses that could expose accounts, functionality, or sensitive data.

• APIs and integrations: Test interfaces connecting EHRs, providers, applications, and third-party services.

• Authentication and authorization: Determine whether users can access information or functions beyond their intended privileges.

• Cloud infrastructure: Assess exposed services, configurations, storage, and other cloud components.

• Access controls: Examine whether sensitive systems and ePHI are adequately restricted.

• Data exposure: Identify vulnerabilities that could allow unauthorized access to healthcare or personal information.

• Session management: Evaluate weaknesses that could enable account takeover or unauthorized sessions.

Health Tech Providers and Business Associates

Business associates can operate critical systems or process ePHI on behalf of covered entities, making their security posture an important part of the broader healthcare environment. Under the HIPAA Security Rule, applicable administrative, physical, and technical safeguards extend to business associates. For VAPT requirements for health tech providers, testing should therefore be considered alongside the organization's risk profile, contractual security obligations, customer requirements, and the systems used to create, receive, maintain, or transmit ePHI.

Medical Device and Digital Health Manufacturers

Connected medical devices introduce another layer of cybersecurity considerations because vulnerabilities can exist within the device, its software, communications, supporting infrastructure, or associated applications. The FDA's current cybersecurity guidance addresses cybersecurity design, labeling, and documentation for medical devices with cybersecurity risks and discusses requirements associated with Section 524B of the Federal Food, Drug, and Cosmetic Act. As a result, medical device and digital health manufacturers should consider device-specific risks alongside conventional application, network, and infrastructure testing rather than assuming that a standard enterprise VAPT scope covers every relevant cybersecurity concern.

What Should a Healthcare VAPT Assessment Cover?

A healthcare VAPT assessment should be shaped by the organization's technology environment, data flows, and identified risks rather than a generic testing checklist. For healthcare technology providers, the scope may extend across applications, APIs, cloud infrastructure, internal systems, mobile platforms, and connected technologies.

Web Applications

Web applications and patient portals can expose sensitive information if weaknesses exist in authentication, authorization, session management, input validation, or access controls. Testing should examine whether users can access information or functionality beyond their intended permissions and whether application weaknesses could provide a pathway to sensitive systems or data.

APIs

APIs often connect healthcare applications with EHRs, providers, partners, devices, and other data platforms. VAPT should therefore examine how APIs authenticate and authorize users and applications, whether they expose excessive information, enforce appropriate access controls and rate limits, and securely handle sensitive healthcare data throughout these interactions.

Cloud Infrastructure

For healthcare technology providers operating in cloud environments, the assessment may examine externally exposed services, identity and access management, storage configurations, network controls, and other components within the agreed scope. The objective is to identify weaknesses that could expose systems or data or provide an attacker with an opportunity to gain unauthorized access.

Networks and Internal Systems

External defenses are only one part of the security picture. Internal testing can examine what an attacker might be able to do after gaining an initial foothold, including whether network segmentation limits movement, whether excessive privileges can be exploited, and whether internal services or administrative interfaces are unnecessarily exposed.

Mobile and Connected Healthcare Technologies

Mobile applications and connected healthcare technologies introduce additional attack surfaces that may not be captured through conventional network testing. Depending on the technology, VAPT may examine local data storage, authentication, application-to-server communications, APIs, update mechanisms, and other technology-specific weaknesses that could affect sensitive information or connected systems.

Therefore, the appropriate VAPT scope should be determined by the organization's risk analysis, technology architecture, data flows, and applicable obligations. A broader testing scope is not automatically a better one; the goal is to test the systems and attack paths that are most relevant to the organization's actual risk environment.

Key VAPT Requirements for Healthcare Technology Providers

A practical VAPT program should cover more than the testing itself. It should establish what needs to be tested, connect technical findings to healthcare data and business risks, and ensure that identified weaknesses are addressed and verified.

Define the Scope

Start by identifying the technology assets that could introduce security risk. Depending on the organization, this may include web applications, APIs, cloud infrastructure, networks, mobile applications, connected medical devices, databases, externally exposed services, and relevant third-party connections. A clearly defined scope ensures that testing reflects the organization’s actual attack surface rather than focusing only on a limited set of systems.

Identify Systems Handling ePHI

Determine where electronic protected health information (ePHI) is created, received, maintained, processed, and transmitted across the environment. Mapping these systems and data flows helps connect VAPT findings to the organization’s HIPAA risk analysis and makes it easier to understand which vulnerabilities could affect the confidentiality, integrity, or availability of ePHI.

Perform a Vulnerability Assessment

A vulnerability assessment provides visibility into weaknesses that may exist across the defined environment. Scanning can identify known vulnerabilities, missing patches, obsolete software, insecure configurations, and exposed services that require further investigation. HHS specifically identifies vulnerability scanning as one method for identifying vulnerabilities, missing patches, and obsolete software in environments involving ePHI.

Conduct Penetration Testing

Penetration testing takes the assessment further by evaluating whether selected vulnerabilities can actually be exploited and what level of access or impact could result. Depending on the organization’s risk profile, testing may cover external infrastructure, internal networks, web applications, APIs, cloud environments, mobile applications, or connected healthcare technologies. This provides a more practical view of how weaknesses could potentially be used in an attack.

Prioritize Findings Based on Risk

A VAPT assessment may identify numerous vulnerabilities, but treating every finding as equally urgent can make remediation inefficient. Healthcare technology providers should prioritize findings based on factors such as severity, exploitability, potential ePHI exposure, internet exposure, business impact, and the effectiveness of existing security controls. This allows organizations to focus attention on vulnerabilities that present the greatest risk to sensitive information and critical healthcare services.

Remediate and Retest

Finding a vulnerability is not the end of the process. Identified weaknesses should be addressed according to their risk and business impact, followed by retesting where appropriate to determine whether the issue has actually been resolved. Retesting also provides stronger evidence that remediation measures have reduced the identified risk rather than simply documenting that corrective action was planned.

How Often Should VAPT Be Performed?

There is no single VAPT frequency prescribed for every healthcare technology provider under the current HIPAA Security Rule. Instead, the frequency should reflect the organization’s risk profile, technology environment, known vulnerabilities, and changes that could alter its attack surface. VAPT may warrant additional attention after major application releases, new APIs, cloud migrations, significant infrastructure changes, deployment of connected devices, major security incidents, or integration with new third-party systems. For healthcare technology providers, the goal is not simply to test at a fixed interval, but to ensure that security testing remains aligned with the systems, data, and risks the organization operates.

The proposed HIPAA Security Rule provides a useful indication of how these expectations could become more specific. The 2024 Notice of Proposed Rulemaking would require vulnerability scanning at least every six months and penetration testing at least once every 12 months. However, these are proposed requirements, not requirements under the current Security Rule. This distinction is important when evaluating Healthcare penetration testing requirements USA: current HIPAA requirements remain risk-based, while the proposed rule would introduce defined testing intervals for regulated entities. Healthcare technology providers should therefore consider both their present obligations and evolving regulatory expectations when determining an appropriate VAPT schedule.

How Do HIPAA, NIST, FDA, and CISA Fit Into Healthcare VAPT?

VAPT sits within a broader healthcare cybersecurity landscape, where different frameworks and regulatory bodies address different aspects of security. HIPAA establishes security requirements for applicable covered entities and business associates, including requirements for risk analysis and appropriate safeguards for ePHI. NIST provides technical guidance that can inform how organizations plan and perform security testing, including vulnerability scanning and penetration testing. Together, they help connect the regulatory requirement to assess security risks with practical methods for identifying and evaluating technical weaknesses.

For organizations involved in medical devices, FDA cybersecurity requirements and guidance add another layer focused on the security of devices and related technologies. Meanwhile, CISA's Cybersecurity Performance Goals (CPGs) provide voluntary, prioritized cybersecurity practices, including resources relevant to the healthcare sector. These sources should not be treated as interchangeable compliance requirements. Instead, healthcare technology providers can view them as complementary: HIPAA defines applicable regulatory obligations, NIST provides technical security practices and testing guidance, FDA addresses medical-device cybersecurity where applicable, and CISA provides broader cybersecurity priorities. Understanding these distinctions helps organizations develop a VAPT approach that reflects both their regulatory responsibilities and their actual technology environment.

Strengthen Visibility Across Your Healthcare Technology Environment. Explore VAPT Testing to identify vulnerabilities across applications, APIs, cloud infrastructure, networks, and connected systems.

VAPT Checklist for Healthcare Technology Providers

A well-structured VAPT process should cover the activities that take place before, during, and after testing. The following checklist provides a practical framework for healthcare technology providers evaluating vulnerabilities across applications, infrastructure, ePHI environments, and connected technologies.

Before Testing

Begin by defining the scope and identifying the systems that require assessment. Map critical assets and ePHI data flows, identify relevant third-party dependencies, and establish clear rules of engagement for the assessment. This provides testers with a defined understanding of the environment while reducing the risk of critical systems or data flows being overlooked.

During Testing

Testing should reflect the organization’s actual attack surface and risk profile. Depending on the agreed scope, this may include vulnerability scanning, external and internal systems, web applications, APIs, cloud environments, mobile applications, and connected healthcare technologies. The objective is to identify weaknesses across the paths an attacker could realistically use to gain unauthorized access or affect sensitive systems and information.

After Testing

The value of VAPT depends largely on what happens after vulnerabilities are identified. Findings should be classified and prioritized according to factors such as severity, exploitability, ePHI exposure, and business impact. Organizations should address significant vulnerabilities, perform retesting where appropriate, document the results, and track residual risks that remain. This turns VAPT from a one-time testing exercise into a repeatable process for identifying, addressing, and reassessing security risks.

Proactively Identifying and Managing Cybersecurity Risks

For healthcare technology providers, VAPT is ultimately about answering a difficult but important question: If an attacker targeted our environment today, would we know where the weaknesses are and what they could expose? HIPAA’s current risk-based requirements, NIST testing practices, FDA cybersecurity expectations for applicable medical devices, and evolving regulatory proposals all point toward a security approach that goes beyond policies on paper. A well-scoped VAPT program brings technical visibility into applications, APIs, cloud environments, networks, connected technologies, and systems handling ePHI, while giving organizations a clearer basis for prioritizing and reassessing security risks.

Choosing the right certification and assessment partner also matters. As an independent third-party certification body, INTERCERT brings an impartial and objective approach to certification, backed by experienced auditors with industry-specific knowledge and internationally recognized certification services. For healthcare technology organizations seeking to demonstrate a credible commitment to information security, independent certification can add assurance for customers, partners, and other stakeholders. The question is no longer simply whether your organization has tested its systems, it is whether your current VAPT approach can reveal the risks that matter most before an attacker does.